Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 184 articles:
HTML format
Text format



Single Articles


    January 2017
  1. MACANAS-PIRARD P, Quezada T, Navarrete L, Broekhuizen R, et al
    The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
    PLoS One. 2017;12:e0168888.
    PubMed     Text format     Abstract available


  2. MIN C, Moore N, Shearstone JR, Quayle SN, et al
    Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    PLoS One. 2017;12:e0169128.
    PubMed     Text format     Abstract available


  3. KREIS C, Lupatsch JE, Niggli F, Egger M, et al
    Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion.
    PLoS One. 2017;12:e0170020.
    PubMed     Text format     Abstract available


  4. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Text format     Abstract available


  5. YANG L, Sun H, Cao Y, Xuan B, et al
    GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
    PLoS One. 2017;12:e0170630.
    PubMed     Text format     Abstract available


  6. NAGEL S, Pommerenke C, Scherr M, Meyer C, et al
    NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
    PLoS One. 2017;12:e0171164.
    PubMed     Text format     Abstract available


  7. EL MISSIRY M, Hjorth-Hansen H, Richter J, Olson-Stromberg U, et al
    Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
    PLoS One. 2017;12:e0171041.
    PubMed     Text format     Abstract available


  8. SHOU LH, Cao D, Dong XH, Fang Q, et al
    Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
    PLoS One. 2017;12:e0171608.
    PubMed     Text format     Abstract available


  9. STEFANKO A, Thiede C, Ehninger G, Simons K, et al
    Lipidomic approach for stratification of acute myeloid leukemia patients.
    PLoS One. 2017;12:e0168781.
    PubMed     Text format     Abstract available


  10. MINAGAWA K, Jamil MO, Al-Obaidi M, Pereboeva L, et al
    Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
    PLoS One. 2017;12:e0172640.
    PubMed     Text format     Abstract available


  11. KO PS, Liu YC, Yeh CM, Gau JP, et al
    The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.
    PLoS One. 2017;12:e0172029.
    PubMed     Text format     Abstract available


  12. LI Y, Liu S, Wang H, Mai H, et al
    Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
    PLoS One. 2017;12:e0173472.
    PubMed     Text format     Abstract available


  13. GARCIA-GUTIERREZ V, Gomez-Casares MT, Puerta JM, Alonso-Dominguez JM, et al
    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
    PLoS One. 2017;12:e0173532.
    PubMed     Text format     Abstract available


  14. LIN TY, Chen KC, Liu HE, Liu AJ, et al
    Correction: MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    PLoS One. 2017;12:e0173828.
    PubMed     Text format     Abstract available


  15. HOCK BD, MacPherson SA, McKenzie JL
    Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.
    PLoS One. 2017;12:e0172858.
    PubMed     Text format     Abstract available


  16. RAUZAN M, Chuah CT, Ko TK, Ong ST, et al
    The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia.
    PLoS One. 2017;12:e0174107.
    PubMed     Text format     Abstract available


  17. SALZBERG AC, Harris-Becker A, Popova EY, Keasey N, et al
    Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.
    PLoS One. 2017;12:e0173723.
    PubMed     Text format     Abstract available


  18. YANG L, Sun H, Cao Y, Xuan B, et al
    Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
    PLoS One. 2017;12:e0175005.
    PubMed     Text format     Abstract available


  19. LAJOIE M, Drouin S, Caron M, St-Onge P, et al
    Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0174124.
    PubMed     Text format     Abstract available


  20. JABO B, Morgan JW, Martinez ME, Ghamsary M, et al
    Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
    PLoS One. 2017;12:e0174760.
    PubMed     Text format     Abstract available


  21. KALLEMEIJN MJ, de Ridder D, Schilperoord-Vermeulen J, van der Klift MY, et al
    Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia.
    PLoS One. 2017;12:e0175670.
    PubMed     Text format     Abstract available


  22. TSUNAKA M, Shinki H, Koyama T
    Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
    PLoS One. 2017;12:e0175765.
    PubMed     Text format     Abstract available


  23. YE X, Torabi M, Lix LM, Mahmud SM, et al
    Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
    PLoS One. 2017;12:e0175701.
    PubMed     Text format     Abstract available


    January 2016
  24. SOMINTARA S, Leardkamolkarn V, Suttiarporn P, Mahatheeranont S, et al
    Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
    PLoS One. 2016;11:e0146869.
    PubMed     Text format     Abstract available


  25. CHEN W, Xie H, Wang H, Chen L, et al
    Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0146614.
    PubMed     Text format     Abstract available


  26. WONG SM, Liu FH, Lee YL, Huang HM, et al
    MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
    PLoS One. 2016;11:e0148093.
    PubMed     Text format     Abstract available


  27. ZHANG Y, Wu S, Luo D, Zhou J, et al
    Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
    PLoS One. 2016;11:e0147545.
    PubMed     Text format     Abstract available


  28. CHOI HJ, Chung TW, Park MJ, Lee KS, et al
    Paeonia lactiflora Enhances the Adhesion of Trophoblast to the Endometrium via Induction of Leukemia Inhibitory Factor Expression.
    PLoS One. 2016;11:e0148232.
    PubMed     Text format     Abstract available


  29. MIZUGUCHI M, Sasaki Y, Hara T, Higuchi M, et al
    Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax.
    PLoS One. 2016;11:e0148217.
    PubMed     Text format     Abstract available


  30. FOLLIN C, Gabery S, Petersen A, Sundgren PC, et al
    Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
    PLoS One. 2016;11:e0147575.
    PubMed     Text format     Abstract available


  31. HUSAIN I, Sharma A, Kumar S, Malik F, et al
    Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells.
    PLoS One. 2016;11:e0148877.
    PubMed     Text format     Abstract available


  32. IBANEZ M, Carbonell-Caballero J, Garcia-Alonso L, Such E, et al
    The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations.
    PLoS One. 2016;11:e0148346.
    PubMed     Text format     Abstract available


  33. FORERO-CASTRO M, Robledo C, Benito R, Abaigar M, et al
    Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.
    PLoS One. 2016;11:e0148972.
    PubMed     Text format     Abstract available


  34. FISCHER M, Spies-Weisshart B, Schrenk K, Gruhn B, et al
    Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0150632.
    PubMed     Text format     Abstract available


  35. KASAR S, Underbayev C, Hassan M, Ilev I, et al
    Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
    PLoS One. 2016;11:e0149331.
    PubMed     Text format     Abstract available


  36. SHOUVAL R, Labopin M, Unger R, Giebel S, et al
    Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.
    PLoS One. 2016;11:e0150637.
    PubMed     Text format     Abstract available


  37. DUREN RP, Boudreaux SP, Conneely OM
    Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.
    PLoS One. 2016;11:e0150450.
    PubMed     Text format     Abstract available


  38. CHIARENZA A, Manetti F, Petricci E, Ruat M, et al
    Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells.
    PLoS One. 2016;11:e0149919.
    PubMed     Text format     Abstract available


  39. VAN DEN BOOM J, Trusch F, Hoppstock L, Beuck C, et al
    Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1.
    PLoS One. 2016;11:e0151431.
    PubMed     Text format     Abstract available


  40. HASEGAWA K, Tanaka S, Fujiki F, Morimoto S, et al
    Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
    PLoS One. 2016;11:e0152326.
    PubMed     Text format     Abstract available


  41. WANG X, Zhou M, Fu Y, Sun T, et al
    RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2.
    PLoS One. 2016;11:e0152142.
    PubMed     Text format     Abstract available


  42. MILUTINOVIC S, Heynen-Genel S, Chao E, Dewing A, et al
    Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML).
    PLoS One. 2016;11:e0152692.
    PubMed     Text format     Abstract available


  43. FAHRENKROG B, Martinelli V, Nilles N, Fruhmann G, et al
    Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
    PLoS One. 2016;11:e0152321.
    PubMed     Text format     Abstract available


  44. SLOAN CE, Luskin MR, Boccuti AM, Sehgal AR, et al
    A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0153016.
    PubMed     Text format     Abstract available


  45. TENG CJ, Huon LK, Hu YW, Yeh CM, et al
    Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2016;11:e0152909.
    PubMed     Text format     Abstract available


  46. WALLACE J, Hu R, Mosbruger TL, Dahlem TJ, et al
    Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth.
    PLoS One. 2016;11:e0153689.
    PubMed     Text format     Abstract available


  47. ADMONI-ELISHA L, Nakdimon I, Shteinfer A, Prezma T, et al
    Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.
    PLoS One. 2016;11:e0148500.
    PubMed     Text format     Abstract available


  48. FERRELL PB JR, Diggins KE, Polikowsky HG, Mohan SR, et al
    High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy.
    PLoS One. 2016;11:e0153207.
    PubMed     Text format     Abstract available


  49. REBOLLEDA N, Losada-Fernandez I, Perez-Chacon G, Castejon R, et al
    Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
    PLoS One. 2016;11:e0154159.
    PubMed     Text format     Abstract available


  50. CHENG EH, Liu JY, Lee TH, Huang CC, et al
    Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways.
    PLoS One. 2016;11:e0153086.
    PubMed     Text format     Abstract available


  51. POLAK A, Kiliszek P, Sewastianik T, Szydlowski M, et al
    MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
    PLoS One. 2016;11:e0155893.
    PubMed     Text format     Abstract available


  52. LIN TY, Chen KC, Liu HJ, Liu AJ, et al
    MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    PLoS One. 2016;11:e0156260.
    PubMed     Text format     Abstract available


  53. KANDA M, Nagai T, Takahashi T, Liu ML, et al
    Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction.
    PLoS One. 2016;11:e0156562.
    PubMed     Text format     Abstract available


  54. SUZUKI T, Kazuki Y, Oshimura M, Hara T, et al
    Highly Efficient Transfer of Chromosomes to a Broad Range of Target Cells Using Chinese Hamster Ovary Cells Expressing Murine Leukemia Virus-Derived Envelope Proteins.
    PLoS One. 2016;11:e0157187.
    PubMed     Text format     Abstract available


  55. GIALLONGO C, Romano A, Parrinello NL, La Cava P, et al
    Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients.
    PLoS One. 2016;11:e0158392.
    PubMed     Text format     Abstract available


  56. MA Y, Liu L, Jin J, Lou Y, et al
    All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.
    PLoS One. 2016;11:e0158760.
    PubMed     Text format     Abstract available


  57. WARRIS LT, van den Akker EL, Bierings MB, van den Bos C, et al
    Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
    PLoS One. 2016;11:e0158225.
    PubMed     Text format     Abstract available


  58. JONAS BA, Johnson C, Gratzinger D, Majeti R, et al
    Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity.
    PLoS One. 2016;11:e0159189.
    PubMed     Text format     Abstract available


  59. POTENZA L, Vallerini D, Barozzi P, Riva G, et al
    Mucorales-Specific T Cells in Patients with Hematologic Malignancies.
    PLoS One. 2016;11:e0149108.
    PubMed     Text format     Abstract available


  60. ZHOU Y, Zhu J, Gu Z, Yin X, et al
    Efficacy of Exercise Interventions in Patients with Acute Leukemia: A Meta-Analysis.
    PLoS One. 2016;11:e0159966.
    PubMed     Text format     Abstract available


  61. WESTON-BELL NJ, Tapper W, Gibson J, Bryant D, et al
    Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.
    PLoS One. 2016;11:e0149162.
    PubMed     Text format     Abstract available


  62. MATSUSHITA M, Otsuka Y, Tsutsumida N, Tanaka C, et al
    Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies.
    PLoS One. 2016;11:e0146371.
    PubMed     Text format     Abstract available


  63. LI Y, Wei J, Mao X, Gao Q, et al
    Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    PLoS One. 2016;11:e0158827.
    PubMed     Text format     Abstract available


  64. PALLIS M, Harvey T, Russell N
    Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation.
    PLoS One. 2016;11:e0151480.
    PubMed     Text format     Abstract available


  65. WEEKS RJ, Ludgate JL, LeMee G, Morison IM, et al
    TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells.
    PLoS One. 2016;11:e0151341.
    PubMed     Text format     Abstract available


  66. POTUCKOVA E, Zuna J, Hovorkova L, Starkova J, et al
    Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia.
    PLoS One. 2016;11:e0160385.
    PubMed     Text format     Abstract available


  67. BURDA P, Vargova J, Curik N, Salek C, et al
    GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    PLoS One. 2016;11:e0152234.
    PubMed     Text format     Abstract available


  68. TENG CJ, Huon LK, Hu YW, Yeh CM, et al
    Correction: Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2016;11:e0162225.
    PubMed     Text format     Abstract available


  69. EDWARDS H, Rubenstein M, Dombkowski AA, Caldwell JT, et al
    Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia.
    PLoS One. 2016;11:e0161539.
    PubMed     Text format     Abstract available


  70. BIRKENMEIER G, Hemdan NY, Kurz S, Bigl M, et al
    Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells.
    PLoS One. 2016;11:e0161571.
    PubMed     Text format     Abstract available


  71. POHLEN M, Thoennissen NH, Braess J, Thudium J, et al
    Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
    PLoS One. 2016;11:e0160871.
    PubMed     Text format     Abstract available


  72. SONTAKKE P, Koczula KM, Jaques J, Wierenga AT, et al
    Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation.
    PLoS One. 2016;11:e0153226.
    PubMed     Text format     Abstract available


  73. CEPPI F, Duval M, Leclerc JM, Laverdiere C, et al
    Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy.
    PLoS One. 2016;11:e0160310.
    PubMed     Text format     Abstract available


  74. KUZNETSOVA IS, Labutina EV, Hunter N
    Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004.
    PLoS One. 2016;11:e0162710.
    PubMed     Text format     Abstract available


  75. CHEN D, Zheng J, Gerasimcik N, Lagerstedt K, et al
    The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia.
    PLoS One. 2016;11:e0162638.
    PubMed     Text format     Abstract available


  76. MULSOW K, Enzlein T, Delebinski C, Jaeger S, et al
    Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.
    PLoS One. 2016;11:e0153825.
    PubMed     Text format     Abstract available


  77. ZHAO S, Liu W, Li Y, Liu P, et al
    Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia.
    PLoS One. 2016;11:e0163328.
    PubMed     Text format     Abstract available


  78. KHAN N, Hills RK, Knapper S, Steadman L, et al
    Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0163291.
    PubMed     Text format     Abstract available


  79. SCHLIEMANN C, Gerss J, Wiebe S, Mikesch JH, et al
    A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0164499.
    PubMed     Text format     Abstract available


  80. XIE M, Jiang Q, Li L, Zhu J, et al
    HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants.
    PLoS One. 2016;11:e0164238.
    PubMed     Text format     Abstract available


  81. ZHANG M, Fu H, Lai X, Tan Y, et al
    Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
    PLoS One. 2016;11:e0163599.
    PubMed     Text format     Abstract available


  82. WASS M, Hitz F, Schaffrath J, Muller-Tidow C, et al
    Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0164587.
    PubMed     Text format     Abstract available


  83. COX CV, Diamanti P, Moppett JP, Blair A, et al
    Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
    PLoS One. 2016;11:e0165210.
    PubMed     Text format     Abstract available


  84. BALDOW C, Thielecke L, Glauche I
    Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia.
    PLoS One. 2016;11:e0165129.
    PubMed     Text format     Abstract available


  85. MAS-Y-MAS S, Barbon M, Teyssier C, Demene H, et al
    The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity.
    PLoS One. 2016;11:e0165139.
    PubMed     Text format     Abstract available


  86. MINAGAWA K, Jamil MO, Al-Obaidi M, Pereboeva L, et al
    In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
    PLoS One. 2016;11:e0166891.
    PubMed     Text format     Abstract available


  87. YANG Y, Kelly PJ, Bai J, Zhang R, et al
    First Molecular Characterization of Bovine Leukemia Virus Infections in the Caribbean.
    PLoS One. 2016;11:e0168379.
    PubMed     Text format     Abstract available


  88. KIM JA, Hwang B, Park SN, Huh S, et al
    Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.
    PLoS One. 2016;11:e0167641.
    PubMed     Text format     Abstract available


  89. BENKISSER-PETERSEN M, Buchner M, Dorffel A, Duhren-von-Minden M, et al
    Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    PLoS One. 2016;11:e0169159.
    PubMed     Text format     Abstract available


  90. CHEN Y, Fang F, Hu Y, Liu Q, et al
    The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.
    PLoS One. 2016;11:e0154183.
    PubMed     Text format     Abstract available


    January 2015
  91. CHEN CY, Huang SY, Cheng A, Chou WC, et al
    High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.
    PLoS One. 2015;10:e0126037.
    PubMed     Text format     Abstract available


  92. NGUYEN TV, Melville A, Nath S, Story C, et al
    Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children.
    PLoS One. 2015;10:e0126233.
    PubMed     Text format     Abstract available


  93. GIOVANNONI F, Damonte EB, Garcia CC
    Cellular promyelocytic leukemia protein is an important dengue virus restriction factor.
    PLoS One. 2015;10:e0125690.
    PubMed     Text format     Abstract available


  94. GONG Q, Zhou L, Xu S, Li X, et al
    High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials.
    PLoS One. 2015;10:e0125612.
    PubMed     Text format     Abstract available


  95. LOPES BA, Emerenciano M, Goncalves BA, Vieira TM, et al
    Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.
    PLoS One. 2015;10:e0127308.
    PubMed     Text format     Abstract available


  96. KUZELOVA K, Brodska B, Fuchs O, Dobrovolna M, et al
    Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.
    PLoS One. 2015;10:e0127637.
    PubMed     Text format     Abstract available


  97. SCHEMIONEK M, Kharabi Masouleh B, Klaile Y, Krug U, et al
    Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.
    PLoS One. 2015;10:e0125783.
    PubMed     Text format     Abstract available


  98. TSUKADA T, Simamura E, Shimada H, Arai T, et al
    The Suppression of Maternal-Fetal Leukemia Inhibitory Factor Signal Relay Pathway by Maternal Immune Activation Impairs Brain Development in Mice.
    PLoS One. 2015;10:e0129011.
    PubMed     Text format     Abstract available


  99. ROJAS M, Golovko G, Khanipov K, Albayrak L, et al
    Secondary Analysis of the NCI-60 Whole Exome Sequencing Data Indicates Significant Presence of Propionibacterium acnes Genomic Material in Leukemia (RPMI-8226) and Central Nervous System (SF-295, SF-539, and SNB-19) Cell Lines.
    PLoS One. 2015;10:e0127799.
    PubMed     Text format     Abstract available


  100. KOTTARIDIS PD, North J, Tsirogianni M, Marden C, et al
    Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
    PLoS One. 2015;10:e0123416.
    PubMed     Text format     Abstract available


  101. TANG JL, Kung HC, Lei WC, Yao M, et al
    High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.
    PLoS One. 2015;10:e0128410.
    PubMed     Text format     Abstract available


  102. VOLLBRECHT C, Mairinger FD, Koitzsch U, Peifer M, et al
    Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    PLoS One. 2015;10:e0129544.
    PubMed     Text format     Abstract available


  103. SU M, Alonso S, Jones JW, Yu J, et al
    All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    PLoS One. 2015;10:e0127790.
    PubMed     Text format     Abstract available


  104. CORNET E, Debliquis A, Rimelen V, Civic N, et al
    Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
    PLoS One. 2015;10:e0128990.
    PubMed     Text format     Abstract available


  105. ARREGI I, Falces J, Olazabal-Herrero A, Alonso-Marino M, et al
    Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport.
    PLoS One. 2015;10:e0130610.
    PubMed     Text format     Abstract available


  106. CHARMSAZ S, Beckett K, Smith FM, Bruedigam C, et al
    EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.
    PLoS One. 2015;10:e0130692.
    PubMed     Text format     Abstract available



  107. Correction: Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients.
    PLoS One. 2015;10:e0131029.
    PubMed     Text format     Abstract available


  108. MILANI M, Laranjeira AB, de Vasconcellos JF, Brandalise SR, et al
    Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
    PLoS One. 2015;10:e0129298.
    PubMed     Text format     Abstract available


  109. HEO SK, Noh EK, Yoon DJ, Jo JC, et al
    Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.
    PLoS One. 2015;10:e0129853.
    PubMed     Text format     Abstract available


  110. RECCHIA AG, Caruso N, Bossio S, Pellicano M, et al
    Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
    PLoS One. 2015;10:e0130360.
    PubMed     Text format     Abstract available


  111. WANG S, Zhou M, Ouyang J, Geng Z, et al
    Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
    PLoS One. 2015;10:e0130343.
    PubMed     Text format     Abstract available


  112. BINDELS LB, Neyrinck AM, Salazar N, Taminiau B, et al
    Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice.
    PLoS One. 2015;10:e0131009.
    PubMed     Text format     Abstract available


  113. TIAN T, Yu S, Liu L, Xue F, et al
    The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations.
    PLoS One. 2015;10:e0131761.
    PubMed     Text format     Abstract available


  114. REYES-LEON A, Juarez-Velazquez R, Medrano-Hernandez A, Cuenca-Roldan T, et al
    Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0130756.
    PubMed     Text format     Abstract available


  115. PAPPANO WN, Guo J, He Y, Ferguson D, et al
    The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.
    PLoS One. 2015;10:e0131716.
    PubMed     Text format     Abstract available


  116. MANCINI M, Leo E, Takemaru K, Campi V, et al
    14-3-3 Binding and Sumoylation Concur to the Down-Modulation of beta-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
    PLoS One. 2015;10:e0131074.
    PubMed     Text format     Abstract available


  117. TORKILDSEN S, Gorunova L, Beiske K, Tjonnfjord GE, et al
    Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32).
    PLoS One. 2015;10:e0132736.
    PubMed     Text format     Abstract available


  118. SIVAGNANALINGAM U, Balys M, Eberhardt A, Wang N, et al
    Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.
    PLoS One. 2015;10:e0132375.
    PubMed     Text format     Abstract available


  119. KAWASHIMA-GOTO S, Imamura T, Tomoyasu C, Yano M, et al
    BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?
    PLoS One. 2015;10:e0132926.
    PubMed     Text format     Abstract available


  120. LI D, Wang L, Zhu H, Dou L, et al
    Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.
    PLoS One. 2015;10:e0132620.
    PubMed     Text format     Abstract available


  121. MILANI M, Laranjeira AB, de Vasconcellos JF, Brandalise SR, et al
    Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
    PLoS One. 2015;10:e0134774.
    PubMed     Text format     Abstract available


  122. BARTELS S, Schipper E, Kreipe HH, Lehmann U, et al
    Comprehensive Molecular Profiling of Archival Bone Marrow Trephines Using a Commercially Available Leukemia Panel and Semiconductor-Based Targeted Resequencing.
    PLoS One. 2015;10:e0133930.
    PubMed     Text format     Abstract available


  123. SUPPER E, Tahir S, Imai T, Inoue J, et al
    Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells.
    PLoS One. 2015;10:e0134026.
    PubMed     Text format     Abstract available


  124. RAMSEY LB, Janke LJ, Payton MA, Cai X, et al
    Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0135134.
    PubMed     Text format     Abstract available


  125. KRUSE M, Wildner R, Barnes G, Martin M, et al
    Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective.
    PLoS One. 2015;10:e0134587.
    PubMed     Text format     Abstract available


  126. BUNACIU RP, Jensen HA, MacDonald RJ, LaTocha DH, et al
    6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.
    PLoS One. 2015;10:e0135668.
    PubMed     Text format     Abstract available


  127. GIOVANNONI F, Damonte EB, Garcia CC
    Correction: Cellular Promyelocytic Leukemia Protein Is an Important Dengue Virus Restriction Factor.
    PLoS One. 2015;10:e0137040.
    PubMed     Text format     Abstract available


  128. XU S, Li X, Zhang J, Chen J, et al
    Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.
    PLoS One. 2015;10:e0135981.
    PubMed     Text format     Abstract available


  129. HAN Y, Ye A, Zhang Y, Cai Z, et al
    Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    PLoS One. 2015;10:e0136484.
    PubMed     Text format     Abstract available


  130. DE CECCO L, Capaia M, Zupo S, Cutrona G, et al
    Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
    PLoS One. 2015;10:e0134706.
    PubMed     Text format     Abstract available


  131. DE VASCONCELLOS JF, Laranjeira AB, Leal PC, Bhasin MK, et al
    SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1.
    PLoS One. 2015;10:e0134783.
    PubMed     Text format     Abstract available


  132. BUEHRING GC, Shen HM, Jensen HM, Jin DL, et al
    Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study.
    PLoS One. 2015;10:e0134304.
    PubMed     Text format     Abstract available


  133. SHI F, Len Y, Gong Y, Shi R, et al
    Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    PLoS One. 2015;10:e0136746.
    PubMed     Text format     Abstract available


  134. YOSHIDA H, Imamura T, Saito AM, Takahashi Y, et al
    Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0136428.
    PubMed     Text format     Abstract available


  135. MIKOSIK A, Henc I, Ruckemann-Dziurdzinska K, Frackowiak JE, et al
    Increased mu-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.
    PLoS One. 2015;10:e0136615.
    PubMed     Text format     Abstract available


  136. KRIANGKUM J, Motz SN, Mack T, Beiggi S, et al
    Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
    PLoS One. 2015;10:e0137232.
    PubMed     Text format     Abstract available



  137. Correction: Increased mu-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.
    PLoS One. 2015;10:e0139063.
    PubMed     Text format     Abstract available


  138. NAKASE K, Kita K, Kyo T, Ueda T, et al
    Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor alpha-Chain (CD25) Expression Predicts a Poor Prognosis.
    PLoS One. 2015;10:e0128998.
    PubMed     Text format     Abstract available


  139. ISHIZAWA J, Kojima K, McQueen T, Ruvolo V, et al
    Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs.
    PLoS One. 2015;10:e0138377.
    PubMed     Text format     Abstract available



  140. Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
    PLoS One. 2015;10:e0138263.
    PubMed     Text format     Abstract available


  141. CABRERA M, Gomez N, Remes Lenicov F, Echeverria E, et al
    G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound.
    PLoS One. 2015;10:e0136878.
    PubMed     Text format     Abstract available


  142. GEORGE AA, Paz H, Fei F, Kirzner J, et al
    Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0137917.
    PubMed     Text format     Abstract available


  143. YEPES S, Torres MM, Andrade RE
    Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions.
    PLoS One. 2015;10:e0137132.
    PubMed     Text format     Abstract available


  144. BORTHAKUR G, Duvvuri S, Ruvolo V, Tripathi DN, et al
    MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation.
    PLoS One. 2015;10:e0139254.
    PubMed     Text format     Abstract available


  145. VAIDYA S, Vundinti BR, Shanmukhaiah C, Chakrabarti P, et al
    Evolution of BCR/ABL gene mutation in CML is time dependent and dependent on the pressure exerted by tyrosine kinase inhibitor.
    PLoS One. 2015;10:e0114828.
    PubMed     Text format     Abstract available


  146. GOPALAKRISHNAPILLAI A, Kolb EA, Dhanan P, Mason RW, et al
    Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.
    PLoS One. 2015;10:e0140564.
    PubMed     Text format     Abstract available


  147. GRYWALSKA E, Rolinski J, Pasiarski M, Korona-Glowniak I, et al
    High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.
    PLoS One. 2015;10:e0140178.
    PubMed     Text format     Abstract available


  148. BRUCE A, Evans R, Mezan R, Shi L, et al
    Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0140506.
    PubMed     Text format     Abstract available


  149. WINSHIP A, Correia J, Zhang JG, Nicola NA, et al
    Leukemia Inhibitory Factor (LIF) Inhibition during Mid-Gestation Impairs Trophoblast Invasion and Spiral Artery Remodelling during Pregnancy in Mice.
    PLoS One. 2015;10:e0129110.
    PubMed     Text format     Abstract available


  150. HOJJAT-FARSANGI M, Jeddi-Tehrani M, Daneshmanesh AH, Mozaffari F, et al
    Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
    PLoS One. 2015;10:e0142310.
    PubMed     Text format     Abstract available


  151. BRASIER AR, Zhao Y, Spratt HM, Wiktorowicz JE, et al
    Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
    PLoS One. 2015;10:e0143165.
    PubMed     Text format     Abstract available


  152. YANG YL, Yen CT, Pai CH, Chen HY, et al
    A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0142863.
    PubMed     Text format     Abstract available


  153. PAIVA C, Godbersen JC, Soderquist RS, Rowland T, et al
    Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.
    PLoS One. 2015;10:e0143685.
    PubMed     Text format     Abstract available


  154. JANG SH, Lee S, Chung HY
    Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
    PLoS One. 2015;10:e0143240.
    PubMed     Text format     Abstract available


  155. HERNANDEZ JA, Hernandez-Sanchez M, Rodriguez-Vicente AE, Grossmann V, et al
    A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
    PLoS One. 2015;10:e0143073.
    PubMed     Text format     Abstract available


  156. CUOMO RE, Garland CF, Gorham ED, Mohr SB, et al
    Low Cloud Cover-Adjusted Ultraviolet B Irradiance Is Associated with High Incidence Rates of Leukemia: Study of 172 Countries.
    PLoS One. 2015;10:e0144308.
    PubMed     Text format     Abstract available


  157. HASEGAWA K, Tanaka S, Fujiki F, Morimoto S, et al
    An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells.
    PLoS One. 2015;10:e0144594.
    PubMed     Text format     Abstract available


  158. DING X, Jiang W, Zhou P, Liu L, et al
    Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).
    PLoS One. 2015;10:e0145023.
    PubMed     Text format     Abstract available


  159. SAKAGUCHI H, Muramatsu H, Okuno Y, Makishima H, et al
    Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.
    PLoS One. 2015;10:e0145394.
    PubMed     Text format     Abstract available



  160. Correction: Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
    PLoS One. 2015;10:e0146203.
    PubMed     Text format     Abstract available


  161. LIU N, Li P, Zang S, Liu Q, et al
    Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
    PLoS One. 2015;10:e0116880.
    PubMed     Text format     Abstract available


  162. GANJALI M, Baghfalaki T, Berridge D
    Robust modeling of differential gene expression data using normal/independent distributions: a Bayesian approach.
    PLoS One. 2015;10:e0123791.
    PubMed     Text format     Abstract available


  163. RAC M, Krupka M, Binder S, Sedlarova M, et al
    Oxidative damage of U937 human leukemic cells caused by hydroxyl radical results in singlet oxygen formation.
    PLoS One. 2015;10:e0116958.
    PubMed     Text format     Abstract available


  164. SHANG W, Ning Y, Xu X, Li M, et al
    Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    PLoS One. 2015;10:e0126016.
    PubMed     Text format     Abstract available


  165. MAURA F, Mosca L, Fabris S, Cutrona G, et al
    Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.
    PLoS One. 2015;10:e0118801.
    PubMed     Text format     Abstract available


  166. GUO J, Roberts L, Chen Z, Merta PJ, et al
    JAK2V617F drives Mcl-1 expression and sensitizes hematologic cell lines to dual inhibition of JAK2 and Bcl-xL.
    PLoS One. 2015;10:e0114363.
    PubMed     Text format     Abstract available


  167. TRISSAL MC, DeMoya RA, Schmidt AP, Link DC, et al
    MicroRNA-223 regulates granulopoiesis but is not required for HSC maintenance in mice.
    PLoS One. 2015;10:e0119304.
    PubMed     Text format     Abstract available


  168. CHANET R, Kienda G, Heneman-Masurel A, Vernis L, et al
    Yeast Assay Highlights the Intrinsic Genomic Instability of Human PML Intron 6 over Intron 3 and the Role of Replication Fork Proteins.
    PLoS One. 2015;10:e0129222.
    PubMed     Text format     Abstract available


  169. NIAVARANI A, Currie E, Reyal Y, Anjos-Afonso F, et al
    APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
    PLoS One. 2015;10:e0120089.
    PubMed     Text format     Abstract available


  170. RETA C, Altamirano L, Gonzalez JA, Diaz-Hernandez R, et al
    Segmentation and Classification of Bone Marrow Cells Images Using Contextual Information for Medical Diagnosis of Acute Leukemias.
    PLoS One. 2015;10:e0130805.
    PubMed     Text format     Abstract available


  171. BAUMER N, Baumer S, Haak M, Koschmieder S, et al
    A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis.
    PLoS One. 2015;10:e0129147.
    PubMed     Text format     Abstract available


  172. BACHAS C, Schuurhuis GJ, Zwaan CM, van den Heuvel-Eibrink MM, et al
    Gene expression profiles associated with pediatric relapsed AML.
    PLoS One. 2015;10:e0121730.
    PubMed     Text format     Abstract available


  173. MUSHTAQ M, Darekar S, Klein G, Kashuba E, et al
    Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells.
    PLoS One. 2015;10:e0136142.
    PubMed     Text format     Abstract available


  174. KUTSZEGI N, Semsei AF, Gezsi A, Sagi JC, et al
    Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.
    PLoS One. 2015;10:e0140136.
    PubMed     Text format     Abstract available


  175. CARON JM, Caron JM
    Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.
    PLoS One. 2015;10:e0141565.
    PubMed     Text format     Abstract available


  176. HAYES JE, Trynka G, Vijai J, Offit K, et al
    Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements.
    PLoS One. 2015;10:e0139360.
    PubMed     Text format     Abstract available


    January 2014
  177. HUET S, Cony-Makhoul P, Heiblig M, Tigaud I, et al
    Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.
    PLoS One. 2014;9:e106250.
    PubMed     Text format     Abstract available



  178. Expression of concern: Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
    PLoS One. 2014;9:e99923.
    PubMed     Text format    


  179. PASTORE F, Pastore A, Wittmann G, Hiddemann W, et al
    The role of therapeutic leukapheresis in hyperleukocytotic AML.
    PLoS One. 2014;9:e95062.
    PubMed     Text format     Abstract available


  180. MARKEY FB, Ruezinsky W, Tyagi S, Batish M, et al
    Fusion FISH imaging: single-molecule detection of gene fusion transcripts in situ.
    PLoS One. 2014;9:e93488.
    PubMed     Text format     Abstract available


  181. CORDOVA EJ, Martinez-Hernandez A, Uribe-Figueroa L, Centeno F, et al
    The NRF2-KEAP1 pathway is an early responsive gene network in arsenic exposed lymphoblastoid cells.
    PLoS One. 2014;9:e88069.
    PubMed     Text format     Abstract available


  182. ALAVANJA MC, Hofmann JN, Lynch CF, Hines CJ, et al
    Non-hodgkin lymphoma risk and insecticide, fungicide and fumigant use in the agricultural health study.
    PLoS One. 2014;9:e109332.
    PubMed     Text format     Abstract available


  183. KUPPUSAMY H, Ogmundsdottir HM, Baigorri E, Warkentin A, et al
    Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.
    PLoS One. 2014;9:e100691.
    PubMed     Text format     Abstract available


  184. HWANG KK, Trama AM, Kozink DM, Chen X, et al
    IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria.
    PLoS One. 2014;9:e90725.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: